Early weight loss during the neonatal period may be associated with the onset of hyperbilirubinemia, potentially allowing early identification of at-risk patients, according to a recently published study in the International Journal of Pharmacy Research and Technology.
Neonatal hyperbilirubinemia is a common complication in newborns and can occur as a symptom of hemolytic disease of the fetus and newborn (HDFN).
Given the risks associated with hyperbilirubinemia—particularly permanent neurological damage or kernicterus—there is a growing need to identify risk factors that enable physicians to detect at-risk newborns early and prevent complications.
The researchers aimed to assess the association between newborn weight loss during the first 72 hours of life and the development of hyperbilirubinemia. This observational study included over 350 newborns who had lost at least 7% of their total body weight in the first three days of life.
Results showed that more than 60% of these newborns developed hyperbilirubinemia shortly afterward. Furthermore, there was a strong correlation between the amount of weight lost and the severity of hyperbilirubinemia.
Although the study did not include patients with HDFN, the findings have indirect implications for them. Weight monitoring represents a non-invasive, cost-free method for identifying at-risk patients. Early intervention in newborns with both weight loss and HDFN risk factors could help prevent severe complications of HDFN-associated hyperbilirubinemia.
“Healthcare providers should implement standardized daily weight monitoring practices for all term neonates during the first 72 hours of life to identify weight loss patterns exceeding 7.8% at 72 hours, as this threshold has optimal predictive performance for identifying term neonates at risk of developing significant hyperbilirubinemia,” the authors concluded.
Understanding neonatal hyperbilirubinemia
Neonatal hyperbilirubinemia can result from various causes, including red blood cell destruction (as in HDFN), impaired liver function, or infection. While most cases are self-limited, severe cases can lead to kernicterus with long-lasting consequences or even death.
Treatment options include phototherapy with blue-green light and exchange blood transfusions.
Sign up here to get the latest news, perspectives, and information about HDFN sent directly to your inbox. Registration is free and only takes a minute.
